Kabra Drugs informs about disclosure

01 Feb 2018 Evaluate

Kabra Drugs has informed about disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

5.15 0.00 (0.00%)
19-Oct-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1017.25
Cipla 1105.05
Dr. Reddys Lab 4362.40
Lupin 769.75
Zydus Lifesciences 405.40
View more..